Definitive Healthcare Corp Stock Market Value
| DH Stock | USD 1.69 0.20 10.58% |
| Symbol | Definitive |
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Definitive Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Definitive Healthcare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Definitive Healthcare.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Definitive Healthcare on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Definitive Healthcare Corp or generate 0.0% return on investment in Definitive Healthcare over 90 days. Definitive Healthcare is related to or competes with National Research, TruBridge, Spok Holdings, Kindly MD, Sophia Genetics, Kyverna Therapeutics, and Editas Medicine. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United S... More
Definitive Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Definitive Healthcare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Definitive Healthcare Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 30.23 | |||
| Value At Risk | (5.53) | |||
| Potential Upside | 4.85 |
Definitive Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Definitive Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Definitive Healthcare's standard deviation. In reality, there are many statistical measures that can use Definitive Healthcare historical prices to predict the future Definitive Healthcare's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (0.45) |
Definitive Healthcare February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 2.64 | |||
| Coefficient Of Variation | (867.85) | |||
| Standard Deviation | 4.06 | |||
| Variance | 16.47 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 30.23 | |||
| Value At Risk | (5.53) | |||
| Potential Upside | 4.85 | |||
| Skewness | (0.22) | |||
| Kurtosis | 5.34 |
Definitive Healthcare Backtested Returns
Definitive Healthcare secures Sharpe Ratio (or Efficiency) of -0.16, which denotes the company had a -0.16 % return per unit of risk over the last 3 months. Definitive Healthcare Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Definitive Healthcare's Mean Deviation of 2.64, standard deviation of 4.06, and Variance of 16.47 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.07, which means a somewhat significant risk relative to the market. Definitive Healthcare returns are very sensitive to returns on the market. As the market goes up or down, Definitive Healthcare is expected to follow. At this point, Definitive Healthcare has a negative expected return of -0.64%. Please make sure to confirm Definitive Healthcare's information ratio, skewness, day typical price, as well as the relationship between the treynor ratio and daily balance of power , to decide if Definitive Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.18 |
Very weak predictability
Definitive Healthcare Corp has very weak predictability. Overlapping area represents the amount of predictability between Definitive Healthcare time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Definitive Healthcare price movement. The serial correlation of 0.18 indicates that over 18.0% of current Definitive Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Definitive Healthcare Correlation, Definitive Healthcare Volatility and Definitive Healthcare Performance module to complement your research on Definitive Healthcare. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Definitive Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.